Personalised medicine and gene therapy: understanding legal and commercial challenges in transnational contexts
27 Mar 2026
Session information
Personalised medicine and gene therapy: understanding legal and commercial challenges in transnational contexts
Friday 27 March (1301 - 1429)
Committee(s)
Healthcare and Life Sciences Law Committee
(Lead)
Intellectual Property and Entertainment Law Committee
Session / Workshop Chair(s)
| Benjamin Gaw | Drew & Napier, Singapore, Singapore; Chair, Development, Innovation and Commercial Transactions Subcommittee |
Speakers
| Renata Fialho de Oliveira | Veirano Advogados, São Paulo, Brazil; Co-Chair, Healthcare and Life Sciences Law Committee |
| Margaux Hall | Ropes & Gray , Washington, District of Columbia, USA |
| Hilary Jones | Formerly at BioNTech UK Ltd , London, England |
| Emmanuel Savoiz | TigenPharma, Lausanne, Switzerland |
| Elisa Stefanini | Portolano Cavallo, Rome, Italy; Chair, Digital Healthcare and Regulation Subcommittee |
| Koen T'Syen | Van Bael & Bellis, Brussels, Belgium |
| Simona Valente | AGC Biologics, Milan, Italy |
| Ilaria Villa | Fondazione Telethon, Rome, Italy |